Evidence map›Paper›PMID 35217004›Full record

ArticleEuropean journal of pharmacology2022

Transforming growth factor-β1/Thrombospondin-1/CD47 axis mediates dysfunction in CD34

Jesmin Jahan, Ildamaris Monte de Oca, Brian Meissner, Shrinidh Joshi, Ahmad Maghrabi, Julio Quiroz-Olvera, Chrisitne Lopez-Yang, Stephen H Bartelmez, Charles Garcia, Yagna P Jarajapu

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jesmin JahanDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, 58108, USA.
Ildamaris Monte de OcaMuseum District Eye Center, Houston, TX, USA.
Brian MeissnerDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, 58108, USA.
Shrinidh JoshiDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, 58108, USA.
Ahmad MaghrabiMuseum District Eye Center, Houston, TX, USA.
Julio Quiroz-OlveraMuseum District Eye Center, Houston, TX, USA.
Chrisitne Lopez-YangMuseum District Eye Center, Houston, TX, USA.
Stephen H BartelmezBetastem Therapeutics, Inc, San Francisco, CA, USA.
Charles GarciaMuseum District Eye Center, Houston, TX, USA.
Yagna P JarajapuDepartment of Pharmaceutical Sciences, College of Health Professions, North Dakota State University, Fargo, ND, 58108, USA. Electronic address: Yagna.Jarajapu@ndsu.edu.
Houston Eye Associates · USNorth Dakota State University · USBetaStem Therapeutics (United States) · US

Funding

Pilot Projects: Core DP30GM103332 · NIGMS · NORTH DAKOTA STATE UNIVERSITY · PI SIBI, MUKUND P. · 2012 to 2016
$4.9M
Targeting Mas Receptor for Diabetic Vascular Disease in Older AdultsR01AG056881 · NIA · NORTH DAKOTA STATE UNIVERSITY · PI Yagna Jarajapu · 2017 to 2026
$3.2M
NIA NIH HHS R01 AG056881NIGMS NIH HHS P30 GM103332
6 · The paper itself

Abstract

Aging with diabetes is associated with impaired vasoprotective functions and decreased nitric oxide (NO) generation in CD34

Indexed as

Diabetes MellitusTransforming Growth Factor beta1AgedCD47 AntigenHumansPhosphorylationThrombospondin 1Transforming Growth Factor betaCD47 AntigenCD47 protein, humanThrombospondin 1Transforming Growth Factor betaTransforming Growth Factor beta1CD34(+) cellsNitric oxideStromal-derived factor-1αThrombospondin-1Transforming growth factor-β1

Identifiers

PMID35217004
PMCPMC8967481
OpenAlexW4213231242

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.